Deficiency of von Willebrand factor-cleaving protease activity in the plasma of malignant patients

By Koo B.-H.   Oh D.   Chung S.Y.   Kim N.K.   Park S.   Jang Y.   Chung K.-H.  

Thrombosis Research, Vol. 105, Iss. 6, 2002-03 ,pp. : 471-476

Elsevier

Access to resources Recommend Favorite

Von Willebrand factor antigen and fibronectin in essential hypertension

By Kloczko J.   Wojtukiewicz M.Z.   Bielawiec M.   Galar M.   Tarasow E.  

Thrombosis Research, Vol. 79, Iss. 3, 1995-08 ,pp. : 331-336

Elsevier

Access to resources Recommend Favorite

A comparison of von Willebrand Factor antigen with platelet activity in vitro in normal and venous occlusion blood

By O'Brien John R.   Tsai Han-Mou   Etherington Michael D.  

Platelets, Vol. 12, Iss. 1, 2001-02 ,pp. : 27-33

Informa Healthcare

Access to resources Recommend Favorite

Von Willebrand Factor in Plasma of Patients with Advanced Stages of Larynx Cancer - Evidence for presence of specific binding sites and modification of von Willebrand factor structure and function

By Paczuski R.   Bialkowska A.   Kotschy M.   Burduk D.   Betlejewski S.  

Thrombosis Research, Vol. 95, Iss. 4, 1999-08 ,pp. : 197-200

Elsevier

Access to resources Recommend Favorite

Plasma Concentrations of von Willebrand Factor in Patients with Angina Pectoris Secondary to Coronary Atherosclerosis or Cardiac Syndrome X

By Botker H.E.   Ingerslev J.  

Thrombosis Research, Vol. 97, Iss. 6, 2000-03 ,pp. : 519-523

Elsevier

Access to resources Recommend Favorite